Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)

HIV-associated neurocognitive disorders (HAND) continues to be prevalent (30–50 %) despite plasma HIVRNA suppression with combination antiretroviral therapy (cART). There is no proven therapy for individuals on suppressive cARTwith HAND. We have shown that the degree of HIV reservoir burden (HIV DNA...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Neurovirol
Κύριοι συγγραφείς: Ndhlovu, Lishomwa C., Umaki, Tracie, Chew, Glen M., Chow, Dominic C., Agsalda, Melissa, Kallianpur, Kalpana J., Paul, Robert, Zhang, Guangxiang, Ho, Erika, Hanks, Nancy, Nakamoto, Beau, Shiramizu, Bruce T., Shikuma, Cecilia M.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2014
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4268390/
https://ncbi.nlm.nih.gov/pubmed/25227930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13365-014-0279-x
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια